Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Gross Margin (2023 - 2025)

Historic Gross Margin for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 60.42%.

  • Mangoceuticals' Gross Margin fell 15700.0% to 60.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 60.61%, marking a year-over-year increase of 20100.0%. This contributed to the annual value of 61.7% for FY2024, which is 27100.0% up from last year.
  • Latest data reveals that Mangoceuticals reported Gross Margin of 60.42% as of Q3 2025, which was down 15700.0% from 53.51% recorded in Q2 2025.
  • In the past 5 years, Mangoceuticals' Gross Margin ranged from a high of 76.11% in Q4 2024 and a low of 42.77% during Q2 2024
  • For the 3-year period, Mangoceuticals' Gross Margin averaged around 59.66%, with its median value being 58.98% (2023).
  • Over the last 5 years, Mangoceuticals' Gross Margin had its largest YoY gain of 177600bps in 2024, and its largest YoY loss of -189200bps in 2024.
  • Quarter analysis of 3 years shows Mangoceuticals' Gross Margin stood at 58.35% in 2023, then skyrocketed by 30bps to 76.11% in 2024, then decreased by -21bps to 60.42% in 2025.
  • Its Gross Margin was 60.42% in Q3 2025, compared to 53.51% in Q2 2025 and 56.78% in Q1 2025.